Ticker Details
Roivant Sciences Ltd. Common Shares
IPO Date:	January 1, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$20.38B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.22 | 2.36%
Avg Daily Range (30 D):	$0.47 | 1.67%
Avg Daily Range (90 D):	$0.41 | 1.67%

Institutional Daily Volume
Avg Daily Volume:	3.08M
Avg Daily Volume (30 D):	3.86M
Avg Daily Volume (90 D):	4.94M

Trade Size
Avg Trade Size (Sh.):	142
Avg Trade Size (Sh.) (30 D):	82
Avg Trade Size (Sh.) (90 D):	99

Institutional Trades
Total Institutional Trades:	4,010
Avg Institutional Trade:	$4.05M
Avg Institutional Trade (30 D):	$6.83M
Avg Institutional Trade (90 D):	$5.85M
Avg Institutional Trade Volume:	.3M
Avg Institutional Trades (Per Day):	4

Market Closing Trades
Avg Closing Trade:	$11.03M
Avg Closing Trade (30 D):	$35.49M
Avg Closing Trade (90 D):	$29.96M
Avg Closing Volume:	819.46K

News

Apr 2, 2026 @ 9:00 AM Priovant Expands Brepocitinib Development Program ... Source: Na

Mar 28, 2026 @ 7:00 PM New England Journal of Medicine Publishes Positive... Source: Priovant Therapeutics / Roivant Sciences

Mar 5, 2026 @ 7:42 PM 9 Biotech Stocks Trading Far Below Fair Value With... Source: David Wagner

Mar 4, 2026 @ 1:14 PM Moderna's $950 Million Settlement Clears Legal Ove... Source: Vandana Singh

Feb 13, 2026 @ 8:21 PM Healthcare REIT Posts 16.4% NOI Growth as Shares S... Source: Jonathan Ponciano

Financials
	TTM	Q3 2026	Q2 2026
Basic EPS	$-1.17	$-.38	$-.17
Diluted EPS	$-1.17	$-.38	$-.17
Revenue	$13.31M	$2M	$1.57M
Gross Profit
Net Income / Loss	$-1006.03M	$-313.7M	$-166.04M
Operating Income / Loss	$-1215.27M	$-339.15M	$-306.23M
Cost of Revenue
Net Cash Flow	$-514.87M	$241.18M	$-2.66M
PE Ratio